Current Vascular Pharmacology

Papers
(The H4-Index of Current Vascular Pharmacology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Response to the Letter to the Editor: Rare Endocrine Disorders and Peripheral Arterial Disease27
Efficacy and Safety of Sarpogrelate on Symptom Improvement in Patients with Peripheral Arterial Disease (PAD) and/or Being at Risk of PAD: A Single Arm, Multi-Centered, Open-Label Trial26
MDMB-FUBINACA Influences Brain Angiogenesis and the Expression of VEGF, ANG-1, and ANG-225
Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India22
Acknowledgement to Reviewers13
P2Y12 Inhibitor or Aspirin Monotherapy in Patients with Coronary Artery Disease: is it Time for a Paradigm Shift?11
A Nutraceutical Compound Containing a Low Dose of Monacolin K, Polymethoxyflavones, Phenolic Acids, Flavonoids, and Hydroxytyrosol Improves HDL Functionality10
Clinical and Laboratory Evaluation of Acute Pericarditis Associated with Antinuclear Antibodies Positivity9
Response to Athyros and Colleagues: Inflammation and LDL Reduction9
0.067441940307617